In this issue:
Radiographic and clinical PFS as surrogates for OS in mHSPC
PSMA-targeting alpha emitter for mCRPC
Concomitant medication effects in metastatic prostate cancer
Glucocorticoid receptor antagonist + enzalutamide for mCRPC
PSAD on MRI for detecting clinically significant prostate cancer
Gallium-68 PSMA PET/CT in AS
Prognosis of Gleason score 9-10 prostatic adenocarcinoma
Identification of genes with rare loss of function variants
18F-DCFPyL-PSMA PET/CT pretreatment in prostate cancer
177Lu-PSMA-617 before radical prostatectomy in high-risk localised prostate cancer
Please login below to download this issue (PDF)